Kellman Pharmaceutical Services (KPS) has been selected as a Functional Service Provider (FSP) for GlobeImmune clinical trials. KPS will provide data management and cost containment expertise through data monitoring and reporting.
GlobeImmune is a private biopharmaceutical company developing therapeutic vaccines called Tarmogens for the treatment of cancer and infectious diseases.
“We were brought in to provide a more efficient monitoring alternative and are succeeding,” explains KPS President David Kelly. “We look forward to expanding our relationship and scope of services for the company in the future.”